Journals / Experimed / 2022 / Cilt: 12 - Sayı: 3

Assessing E-Cadherin and Connexin 43 Gene Expressions in Colorectal Cancer

Journal
Experimed
Pages
119–124
Publication Date
2022-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The results show the expression level of Cx43 to decrease 14-fold in tumor tissue compared to normal tissue (p<0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Dysregulation of cellular adhesion is one of the main mechanisms responsible for tumor initiation, proliferation, and survival.
📊
Key Findings & Data:Connexin 43 (Cx43) is a gap junction protein that plays a central role in cell-cycle regulation and has an important function in carcinogenesis.
💡
Conclusion & Impact:Results: The results show the expression level of Cx43 to decrease 14-fold in tumor tissue compared to normal tissue (p<0.05).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Colorectal cancer · cell adhesion · connexin 43

Abstract

Objective: Dysregulation of cellular adhesion is one of the main mechanisms responsible for tumor initiation, proliferation, and survival. E-cadherin is a cell adhesion molecule associated with tissue invasion and metastasis in most epithelial cancers. Gap junctions are known as small molecular channels that allow communication between neighboring cells and consist of connexin molecules. Connexin 43 (Cx43) is a gap junction protein that plays a central role in cell-cycle regulation and has an important function in carcinogenesis. The present study aimed to evaluate the expression levels of E-cadherin and Cx43 in colorectal cancer patients using clinical and prognostic parameters.Materials and Methods: The quantitative real-time polymerase chain reaction (qRT-PCR) method was utilized to characterize the expression patterns of the E-cadherin and Cx43 genes in tumor and adjacent non-tumoral colon tissues from 32 colorectal cancer patients. Analysis of gene expression data was carried out using the delta-CT method. Results: The results show the expression level of Cx43 to decrease 14-fold in tumor tissue compared to normal tissue (p<0.05). However, the study could find no significant difference with regard to E-cadherin expression.Conclusion: The research provides valuable clues to the elucidation of tumor development and metastatic processes for further studies.

🔖

Cite This Article

SÜRMEN, S., ARIKAN, S., KAHRAMAN, Ö. T., SÜRMEN, M. G., CACINA, C., YAYLIM, İ. (2022). Assessing E-Cadherin and Connexin 43 Gene Expressions in Colorectal Cancer. Experimed, Cilt: 12 - Sayı: 3, 119–124. https://ajindex.com/articles/878263

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nalewajska M, Marchelek-Mysliwiec M, Opara-Bajerowicz M, Dziedziejko V, Pawlik A. Connexins-therapeutic targets in cancers. Int J Mol Sci 2020
  2. 21(23): 9119. [CrossRef] google scholar 2. Bonacquisti EE and Nguyen J. Connexin 43 (Cx43) in cancer: Implications for therapeutic approaches via gap junctions. Cancer Lett 2019
  3. [CrossRef] google scholar 3. Wu JI and Wang LH. Emerging roles of gap junction proteins connexins in cancer metastasis, chemoresistance and clinical application. J Biomed Sci 2019
  4. 26(1): 8. [CrossRef] google scholar 4. Tang B, Peng ZH, Yu PW, Yu G, Qian F. Expression and significance of Cx43 and E-cadherin in gastric cancer and metastatic lymph nodes. Med Oncol 2011
  5. 28(2): 502-8. [CrossRef] google scholar 5. Gall TM, Frampton AE. Gene of the month: E-cadherin (CDH1). J Clin Pathol 2013
  6. 66(11): 928-32. [CrossRef] google scholar 6. Kaszak I, Witkowska-Pilaszewicz O, Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F, Jurka P. Role of cadherins in cancer-A review. Int J Mol Sci 2020
  7. [CrossRef] google scholar 7. Techasen A, Loilome W, Namwat N, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H, Yongvanit P. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. Tumour Biol 2014
  8. 35(9): 864552. [CrossRef] google scholar 8. Berx G, van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 2009
  9. 1(6): a003129. [CrossRef] google scholar 9. He X, Chen Z, Jia M, Zhao X. Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis. PLoS One 2013
  10. 8(7): e70858. [CrossRef] google scholar 10. Peng J, Qi S, Wang P, Li W, Song L, Liu C, et al. F. Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer. Future Oncol 2016
  11. 12(5): 715-26. [CrossRef] google scholar 11. Shargh SA, Sakizli M, Khalaj V, Movafagh A, Yazdi H, Hagigatjou E, et al. Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor. Med Oncol 2014
  12. 31(11): 250. [CrossRef] google scholar 12. Xu HT, Li QC, Zhang YX, Zhao Y, Liu Y, Yang ZQ, et al. Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia Histochem Cytobiol 2008
  13. 46(3): 315-21. [CrossRef] google scholar 13. Gassmann P, Haier J. The tumor cell-host or